BV

Balaji Venkateswarlu Sanka

Director Director DIN 02010148
DIN 02010148 First appointment Jan 2008 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Balaji Venkateswarlu Sanka

Data last updated:

Balaji Venkateswarlu Sanka was a Director at Ortin Global Limited (2008–2024) and Director at Ortin Biotech Private Limited (from 2008). The companies operate in Chemicals.

DIN 02010148
Primary Designation Director
Industry Chemicals
First Appointment 29 Jan 2008
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ortin Global Limited L68200TG1986PLC006885
Director29 Jan 20081986₹6.06 Cr (FY 2023)Active
Ortin Biotech Private Limited U01407TG2008PTC058776
Director23 Apr 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ortin Biotech Private Limited
Ortin Global Limited
Premium access

Shareholding and investment profile for Balaji Venkateswarlu Sanka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balaji Venkateswarlu Sanka

Balaji Venkateswarlu Sanka was first appointed on 29 Jan 2008 as Director at Ortin Global Limited.

Balaji Venkateswarlu Sanka held 2 earlier board appointments: Ortin Global Limited (Director, 29 Jan 2008 to 30 Sep 2024); Ortin Biotech Private Limited (Director, from 23 Apr 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available